Nav: Home

New national study finds Crohn's disease diagnosis difficult to obtain and life altering

March 01, 2016

Philadelphia, March 1, 2016 - In a new national survey of Crohn's disease patients, Health Union reveals that it was not uncommon for patients to see multiple healthcare professionals (HCPs), have numerous office visits, and endure multiple diagnostic tests before receiving a diagnosis. Results demonstrate an impact on such things as the ability to work or exercise, but also on overall quality of life and social activities. Respondents wished more people understood the disease and its impact.

Crohn's disease is a chronic inflammatory disease of the digestive tract affecting about 780,000 people in the U.S. Typical symptoms include abdominal pain, diarrhea, weight loss, and fever. In addition, as an inflammatory disease, Crohn's can have symptoms outside of the digestive tract affecting the joints, skin, eyes, and liver.

The exact cause of Crohn's is unknown. It is believed that it may be an autoimmune reaction - the immune system overreacts and attacks the body's healthy cells. The survey shows that 45% of respondents had a family member with an autoimmune disease other than Crohn's. Forty-two percent had a family member also diagnosed with an inflammatory bowel disease, such as Crohn's or ulcerative colitis. Various stimuli, such as a bacteria or virus, can be responsible for triggering the immune system reaction.

Crohn's disease is often life altering and 22.5% of respondents experienced their first symptoms before the age of 15. Seventy-eight percent say that Crohn's at least sometimes impacts their ability to work and over half report that it often or always negatively impacts their overall quality of life. "I wish people would become more educated about Crohn's Disease," says Paul Richman, patient contributor. "If everyone was more well-read about Crohn's, they would understand how it affects people's lives in every way. They would realize how many people are affected by it, and how hard it is to keep friendships and relationships because of the embarrassing impact it has on our daily lives and routines."

In addition to gastrointestinal issues, 85% of respondents experience complications, with the most prevalent being:
  • arthritis/swollen joints (60%),
  • malnutrition/nutritional difficulties (37%), and
  • anemia (36%).
Crohn's proves very difficult to diagnose with 44% of respondents needing 10 or more office visits and 59% seeing three or more HCPs. More than 3/4 started off with a moderate to severe Crohn's diagnosis.

On a more positive note, once diagnosed, patients actively pursue treatment and are generally happy with their medical care. Eighty-seven percent began treatment immediately or within one month of diagnosis and 95% are under the care of an HCP. Over 3/4 are satisfied with their HCP, with those unsatisfied most often wanting more empathy and education/communication. Patients found HCPs most valuable for monitoring progression, treatment suggestions, and education.

"When it comes to Crohn's, health care providers can do a lot more than just provide treatment. Openly discussing the unsavory aspects of this condition is really important as many patients feel they can't talk to their friends/family. This is why a site like is so important. It provides the open, non-judgmental support so necessary for management," says Tim Armand, president and co-founder of Health Union.

Just as diagnosing Crohn's is difficult, so is symptom management. Less than three percent of respondents were not experiencing symptoms and those with symptoms experienced an average of seven, with 68% citing fatigue/low energy as the most difficult to manage. One quarter have never been in remission and those who have been experienced remission for less than three years. Almost 3/4 experience flares every few months, if not more often. The primary trigger was stress, followed by greasy foods and raw fruits and vegetables.

Finding the right treatment is difficult. More than half of respondents have been on their current treatment plan less than two years and about 70% may be changing in the next year. The most common treatment is biologics. Sixty percent would be interested in participating in a clinical trial.

"Inflammatory Bowel Disease is incredibly difficult to live with and not very well understood by the public. It does makes me feel good to know that some pharmaceutical companies and doctors are working hard for the first time ever to collaborate with patient advocates to improve quality of care for those suffering from this debilitating disease. This helps to mitigate some of the unique challenges faced by IBD patients," said patient contributor Marisa Lauren-Troy.

The Crohn's Disease in America survey was conducted online October 29, 2015, to January 10, 2016, with 2,018 respondents who were diagnosed with Crohn's disease and a resident of the U.S. or U.S. citizen living abroad. More details about the survey are available on request.
About Health Union, LLC and

Health Union inspires people to live better with challenging health conditions - combining new, original content every day with digital, social and mobile technologies to cultivate active, engaged online communities. Health Union platforms are unique ecosystems dedicated to illuminating the voices and experiences of people with migraine, multiple sclerosis, rheumatoid arthritis, hepatitis C, and more. Its services and offerings foster open and honest interactions about these health conditions between and among patients, caregivers, professionals, providers and industry partners to help all stakeholders make more informed decisions about healthcare. is Health Union's newest online community dedicated to Crohn's disease, where patients and supporters of people living with this condition can connect, share experiences and learn about managing the condition.

Health Union

Related Inflammatory Disease Articles:

Cell therapy designed to treat inflammatory bowel disease
The UPV/EHU's NanoBioCel research group has for many years been developing systems enabling cells to be used as drugs.
Antibiotics associated with increased risk of inflammatory bowel disease
Antibiotics use, particularly antibiotics with greater spectrum of microbial coverage, may be associated with an increased risk of new-onset inflammatory bowel disease (IBD) and its subtypes ulcerative colitis and Crohn's disease.
Yes, inflammatory bowel disease and celiac disease are linked
A systematic review and meta-analysis that has determined there is a nine-fold increased risk of having IBD for patients with a previous diagnosis of celiac disease.
The effects of inflammatory bowel disease on pregnancy
Inflammatory bowel disease (IBD) -- including Crohn's disease and ulcerative colitis -- often affects women of childbearing age.
Researchers identify a possible cause and treatment for inflammatory bowel disease
In a study published online in PNAS on Jan. 20, 2020, Prof.
Does inflammatory bowel disease carry certain risks during pregnancy?
Pregnant women with inflammatory bowel disease (IBD) are more likely to undergo delivery by Caesarean section and face certain risks during pregnancy, according to an analysis published in Alimentary Pharmacology & Therapeutics.
Inflammatory bowel disease appears to impact risk of Parkinson's disease
Amsterdam, NL, November 14, 2019 - Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years.
Are steroids used too much for patients with inflammatory bowel disease?
Steroid therapy is commonly used to treat acute attacks of the inflammatory bowel diseases ulcerative colitis and Crohn's disease; however, because it does not provide long-term benefits and it carries a risk of serious side effects, it should not be used to treat inflammatory bowel disease for more than three months.
The diet-microbiome connection in inflammatory bowel disease
A change in diet is a go-to strategy for treating inflammatory bowel diseases like Crohn's.
Edinburgh is global hotspot for inflammatory bowel disease rates
Edinburgh has some of the highest known rates of inflammatory bowel disease in the world and the figure is expected to rise in the next 10 years.
More Inflammatory Disease News and Inflammatory Disease Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Warped Reality
False information on the internet makes it harder and harder to know what's true, and the consequences have been devastating. This hour, TED speakers explore ideas around technology and deception. Guests include law professor Danielle Citron, journalist Andrew Marantz, and computer scientist Joy Buolamwini.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

How to Win Friends and Influence Baboons
Baboon troops. We all know they're hierarchical. There's the big brutish alpha male who rules with a hairy iron fist, and then there's everybody else. Which is what Meg Crofoot thought too, before she used GPS collars to track the movements of a troop of baboons for a whole month. What she and her team learned from this data gave them a whole new understanding of baboon troop dynamics, and, moment to moment, who really has the power.  This episode was reported and produced by Annie McEwen. Support Radiolab by becoming a member today at